These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11572654)

  • 1. ABT-773 (Abbott Laboratories).
    Lawrence LE
    Curr Opin Investig Drugs; 2001 Jun; 2(6):766-72. PubMed ID: 11572654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cethromycin: A-195773, A-195773-0, A-1957730, Abbott-195773, ABT 773.
    Drugs R D; 2007; 8(2):95-102. PubMed ID: 17324007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketolides in the treatment of respiratory infections.
    Zhanel GG; Hoban DJ
    Expert Opin Pharmacother; 2002 Mar; 3(3):277-97. PubMed ID: 11866679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
    Zhanel GG; Hisanaga T; Nichol K; Wierzbowski A; Hoban DJ
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):297-321. PubMed ID: 14661991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
    Reinert RR
    J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-773: a new ketolide antibiotic.
    Dougherty TJ; Barrett JF
    Expert Opin Investig Drugs; 2001 Feb; 10(2):343-51. PubMed ID: 11178346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketolides: the future of the macrolides?
    Nilius AM; Ma Z
    Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMR-3562. Aventis Pharma.
    Ma Z; Florjancic AS
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1702-5. PubMed ID: 11892931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
    Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
    J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin (Cystic Fibrosis Foundation/PathoGenesis).
    Singh MP
    Curr Opin Investig Drugs; 2001 Jun; 2(6):755-65. PubMed ID: 11572653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ketolides and other macrolide antibiotics].
    Yagisawa M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():234-40. PubMed ID: 12717977
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
    Mitten MJ; Meulbroek J; Nukkala M; Paige L; Jarvis K; Oleksijew A; Tovcimak A; Hernandez L; Alder JD; Ewing P; Or YS; Ma Z; Nilius AM; Mollison K; Flamm RK
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2585-93. PubMed ID: 11502533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazufloxacin Toyama Chemical Co.
    Johnson AP
    Curr Opin Investig Drugs; 2000 Sep; 1(1):52-7. PubMed ID: 11249595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nystatin LF (Aronex/Abbott).
    Arikan S; Rex JH
    Curr Opin Investig Drugs; 2001 Apr; 2(4):488-95. PubMed ID: 11566004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro.
    Labro MT; Abdelghaffar H; Babin-Chevaye C
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1096-104. PubMed ID: 15047507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oritavancin. Eli Lilly & Co.
    Barrett JF
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1039-44. PubMed ID: 11892911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of ABT-773 against microaerophilic and fastidious organisms.
    Finegold SM; Molitoris D; Phan VT; Vaisanen ML; Wexler HM
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2716-9. PubMed ID: 12121965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-761 (Abbott).
    Reid JJ
    Curr Opin Investig Drugs; 2001 Jan; 2(1):68-71. PubMed ID: 11527015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.